These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28923773)

  • 1. Plasma separation using a membrane.
    Hirano R; Namazuda K; Suemitsu J; Harashima T; Hirata N
    Transfus Apher Sci; 2017 Oct; 56(5):649-653. PubMed ID: 28923773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double filtration plasmapheresis: Review of current clinical applications.
    Hirano R; Namazuda K; Hirata N
    Ther Apher Dial; 2021 Apr; 25(2):145-151. PubMed ID: 32558286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
    Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
    J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current topics in therapeutic plasmapheresis.
    Nakanishi T; Suzuki N; Kuragano T; Nagasawa Y; Hasuike Y
    Clin Exp Nephrol; 2014 Feb; 18(1):41-9. PubMed ID: 23887747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Massive hollow fiber clotting: a distinct problem in treatment of cryoglobulinemia by membrane plasmapheresis.
    Lai KN; Cheng SC; Vallance-Owen J
    Artif Organs; 1987 Jun; 11(3):259-64. PubMed ID: 3113406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective plasma exchange.
    Ohkubo A; Okado T
    Transfus Apher Sci; 2017 Oct; 56(5):657-660. PubMed ID: 28939369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective removal of triglyceride-rich lipoproteins by plasmapheresis in diabetic patients with severe hypertriglyceridemia.
    Ito H; Naito C; Hayashi H; Kawamura M; Miyazaki S
    Artif Organs; 1989 Jun; 13(3):190-6. PubMed ID: 2764758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
    Wang T; Xu B; Fan R; Liu Z; Gong D
    J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol of comparison of the effects of single plasma exchange and double filtration plasmapheresis on peripheral lymphocyte phenotypes in patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a monocentric prospective study with single-case experimental design.
    Moranne O; Ion IM; Cezar R; Messikh Z; Prelipcean C; Chkair S; Thouvenot E; Tran TA; Corbeau P; Chevallier T
    BMC Neurol; 2022 Aug; 22(1):293. PubMed ID: 35931957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma separator Plasmaflo OP.
    Hirata N; Shizume Y; Shirokaze J; Suemitsu J; Yoshida H; Yamawaki N
    Ther Apher Dial; 2003 Feb; 7(1):64-8. PubMed ID: 12921117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of clinical effects between plasma adsorption and double filtration plasmapheresis in patients with myasthenia gravis.
    Okada H; Moriwaki K; Sugahara S; Nakamoto H; Hosokawa T; Hamaguchi K; Suzuki H
    Ther Apher; 1997 Nov; 1(4):343-7. PubMed ID: 10225728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
    Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
    Gong D; Ji D; Xu B; Liu Z
    Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal kinetics of antibodies against glutamic acid decarboxylase by various plasmapheresis modalities in the treatment of neurological disorders.
    Ohkubo A; Okado T; Kurashima N; Maeda T; Miyamoto S; Nakamura A; Seshima H; Iimori S; Sohara E; Uchida S; Rai T
    Ther Apher Dial; 2014 Jun; 18(3):231-7. PubMed ID: 24965288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma adsorption in critical care.
    Yang KS; Kenpe K; Yamaji K; Tsuda H; Hashimoto H
    Ther Apher; 2002 Jun; 6(3):184-8. PubMed ID: 12109940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous monitoring of blood volume in double filtration plasmapheresis.
    Mineshima M; Eguchi K; Horibe K; Yokoi R; Kaneko I; Kimata N; Sanaka T; Nihei H; Agishi T
    ASAIO J; 1998; 44(5):M465-9. PubMed ID: 9804474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmapheresis with membrane type plasma separator].
    Michikojima A
    Nihon Rinsho; 2004 May; 62 Suppl 5():313-8. PubMed ID: 15197936
    [No Abstract]   [Full Text] [Related]  

  • 19. Membrane plasmapheresis in the United States: a review over the last 20 years.
    Siami GA; Siami FS
    Ther Apher; 2001 Aug; 5(4):315-20. PubMed ID: 11724518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of membrane trapping in plasma fractionator on separative characteristics.
    Mineshima M; Agishi T; Hasuo Y; Kaneko I; Era K; Ota K
    Int J Artif Organs; 1988 May; 11(3):191-4. PubMed ID: 3403057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.